Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Iorio

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Genome Research|February 10, 2017
Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutationsJonathan S Brammeld, Mia Petljak, Inigo Martincorena, et al.
Nature Communications|February 27, 2021
Combinatorial CRISPR screen identifies fitness effects of gene paraloguesNicola A Thompson, Marco Ranzani, Louise van der Weyden, et al.
Nature Communications|December 22, 2019
Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data setsJoshua M Dempster, Clare Pacini, Sasha Pantel, et al.
Nature|April 12, 2019
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screensFiona M Behan, Francesco Iorio, Gabriele Picco, et al.
Cell Reports|October 21, 2016
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid LeukemiaKonstantinos Tzelepis, Hiroko Koike-Yusa, Etienne De Braekeleer, et al.
Cell Reports. Medicine|November 9, 2023
RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severityRoberta Angioni, Matteo Bonfanti, Nicolò Caporale, et al.
Molecular Systems Biology|July 7, 2020
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screensEmanuel Gonçalves, Aldo Segura-Cabrera, Clare Pacini, et al.
Elife|January 19, 2018
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cellsKrishna Kalyan Kolluri, Constantine Alifrangis, Neelam Kumar, et al.
Nature|October 26, 2022
Phenotypic plasticity and genetic control in colorectal cancer evolutionJacob Househam, Timon Heide, George D Cresswell, et al.
Nature Genetics|July 10, 2026
The PRECISE European initiative for cancer-vulnerability mapping and predictionFrancesco Iorio, Mathew J Garnett, Pedro Beltrao, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Genome Research|February 10, 2017
Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutationsJonathan S Brammeld, Mia Petljak, Inigo Martincorena, et al.
Nature Communications|February 27, 2021
Combinatorial CRISPR screen identifies fitness effects of gene paraloguesNicola A Thompson, Marco Ranzani, Louise van der Weyden, et al.
Nature Communications|December 22, 2019
Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data setsJoshua M Dempster, Clare Pacini, Sasha Pantel, et al.
Nature|April 12, 2019
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screensFiona M Behan, Francesco Iorio, Gabriele Picco, et al.
Cell Reports|October 21, 2016
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid LeukemiaKonstantinos Tzelepis, Hiroko Koike-Yusa, Etienne De Braekeleer, et al.
Cell Reports. Medicine|November 9, 2023
RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severityRoberta Angioni, Matteo Bonfanti, Nicolò Caporale, et al.
Molecular Systems Biology|July 7, 2020
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screensEmanuel Gonçalves, Aldo Segura-Cabrera, Clare Pacini, et al.
Elife|January 19, 2018
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cellsKrishna Kalyan Kolluri, Constantine Alifrangis, Neelam Kumar, et al.
Nature|October 26, 2022
Phenotypic plasticity and genetic control in colorectal cancer evolutionJacob Househam, Timon Heide, George D Cresswell, et al.
Nature Genetics|July 10, 2026
The PRECISE European initiative for cancer-vulnerability mapping and predictionFrancesco Iorio, Mathew J Garnett, Pedro Beltrao, et al.
Pageof 10